DK1882946T3 - Fremgangsmåde til at bedømme rheumatold arthritis ved at måle anti-CCP og interleukin 6 - Google Patents

Fremgangsmåde til at bedømme rheumatold arthritis ved at måle anti-CCP og interleukin 6

Info

Publication number
DK1882946T3
DK1882946T3 DK07019998.9T DK07019998T DK1882946T3 DK 1882946 T3 DK1882946 T3 DK 1882946T3 DK 07019998 T DK07019998 T DK 07019998T DK 1882946 T3 DK1882946 T3 DK 1882946T3
Authority
DK
Denmark
Prior art keywords
rheumatoid arthritis
ccp
interleukin
absence
measuring anti
Prior art date
Application number
DK07019998.9T
Other languages
English (en)
Inventor
Norbert Wild
Johann Karl
Veit Peter Grunert
Werner Zolg
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1882946T3 publication Critical patent/DK1882946T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869Interleukin
DK07019998.9T 2003-12-23 2004-12-21 Fremgangsmåde til at bedømme rheumatold arthritis ved at måle anti-CCP og interleukin 6 DK1882946T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03029658 2003-12-23
EP04804125A EP1700129B1 (en) 2003-12-23 2004-12-21 Method of assessing rheumatoid arthritis by measuring anti-ccp and interleukin 6

Publications (1)

Publication Number Publication Date
DK1882946T3 true DK1882946T3 (da) 2010-05-31

Family

ID=34717197

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07019998.9T DK1882946T3 (da) 2003-12-23 2004-12-21 Fremgangsmåde til at bedømme rheumatold arthritis ved at måle anti-CCP og interleukin 6

Country Status (13)

Country Link
US (1) US7846674B2 (da)
EP (2) EP1700129B1 (da)
JP (1) JP4495168B2 (da)
AT (1) ATE458201T1 (da)
CA (1) CA2546312C (da)
CY (1) CY1111229T1 (da)
DE (2) DE602004010432T2 (da)
DK (1) DK1882946T3 (da)
ES (2) ES2297521T3 (da)
PL (1) PL1882946T3 (da)
PT (1) PT1882946E (da)
SI (1) SI1882946T1 (da)
WO (1) WO2005064307A2 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1590469A4 (en) 2002-11-12 2005-12-28 Becton Dickinson Co DIAGNOSIS OF SEPSIS OR SIRS USING BIOLOGICAL MARKERS PROFILES
AU2003291483A1 (en) 2002-11-12 2004-06-03 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
ES2288718T3 (es) * 2004-07-07 2008-01-16 F. Hoffmann-La Roche Ag Panel de multiples marcadores para la diabetes de tipo 1 y de tipo 2.
BRPI0609302A2 (pt) 2005-04-15 2011-10-11 Becton Dickinson Co métodos para prever o desenvolvimento de sepse e para diagnosticar sepse em um indivìduo a ser testado, microarranjo, kit para prever o desenvolvimento de sepse em um indivìduo a ser testado, produto de programa de computador, computador, sistema de computador para determinar se um indivìduo é susceptìvel de desenvolver sepse, sinal digital embutido em uma onda portadora, e, interface gráfica de usuário para determinar se um indivìduo é susceptìvel de desenvolver sepse
US7901896B2 (en) * 2005-07-21 2011-03-08 Wayne State University Asbestos exposure, pleural mesothelioma, and osteopontin levels
FI20050814A0 (fi) * 2005-08-11 2005-08-11 Procollagen Oy Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi
US20090142792A1 (en) * 2007-06-21 2009-06-04 Robinson William H Biomarkers for the diagnosis of autoimmune disease
GB0803107D0 (en) 2008-02-20 2008-03-26 Axis Shield Diagnostics Ltd Method
WO2009115612A1 (en) * 2008-03-21 2009-09-24 Universiteit Hasselt Biomarkers for rheumatoid arthritis
US8669113B2 (en) 2008-04-03 2014-03-11 Becton, Dickinson And Company Advanced detection of sepsis
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
EP2204655A1 (en) 2008-12-23 2010-07-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Diagnostic prediction of rheumatoid arthritis and systemic lupus erythematosus
CN101988924B (zh) * 2009-07-31 2014-06-11 上海科新生物技术股份有限公司 检测血液抗环瓜氨酸多肽抗体的试纸条及制备方法
CN102507918B (zh) * 2011-11-09 2014-10-29 四川新健康成生物股份有限公司 抗环瓜氨酸肽抗体测定试剂盒
US9829493B2 (en) 2013-07-15 2017-11-28 Steven J. Svoboda Methods and apparatus for assessment of risk for joint injury
JP6220222B2 (ja) 2013-10-28 2017-10-25 シスメックス株式会社 関節リウマチの診断を補助するための方法、システム及びコンピュータプログラム製品
EP3256854A1 (en) * 2015-02-13 2017-12-20 F. Hoffmann-La Roche AG Method of assessing rheumatoid arthritis by measuring anti-ccp and anti-pik3cd
AU2016261939A1 (en) 2015-05-12 2018-01-04 The General Hospital Corporation D/B/A Massachusetts General Hospital Autoantigens for diagnosis of rheumatoid arthritis
EP3463441B1 (en) 2016-06-07 2023-10-25 The General Hospital Corporation Identification of a t cell epitope of prevotella copri that induces t cell responses in patients with rheumatoid arthritis
CN109929009B (zh) * 2019-03-20 2021-06-04 深圳市新产业生物医学工程股份有限公司 Ccp肽段、包含其的抗原、试剂、试剂盒及应用
US11367521B1 (en) 2020-12-29 2022-06-21 Kpn Innovations, Llc. System and method for generating a mesodermal outline nourishment program

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
SE500044C2 (sv) * 1985-02-15 1994-03-28 Gambro Lundia Ab Peptidförening, antiserum framställt med användning av denna förening samt användning av föreningen
JP3399948B2 (ja) 1992-06-26 2003-04-28 ザ トラスティーズ オブ プリンストン ユニバーシティ P90抗体またはプローブを用いた前癌細胞または癌細胞の検出方法
US5538897A (en) * 1994-03-14 1996-07-23 University Of Washington Use of mass spectrometry fragmentation patterns of peptides to identify amino acid sequences in databases
FR2752842B1 (fr) 1996-08-30 1998-11-06 Biomerieux Sa Antigenes derives des filaggrines et leur utilisation pour le diagnostic de la polyarthrite rhumatoide
NL1004539C2 (nl) 1996-11-15 1998-05-20 Stichting Tech Wetenschapp Peptide afgeleid van een door auto-antilichamen van patiënten met reumatoïde artritis herkend antigeen, antilichaam daartegen en werkwijze voor het detecteren van auto-immuunantilichamen.
US6410724B1 (en) * 1997-04-07 2002-06-25 Institut Pasteur Diagnostic means useful for predictive assessment of human hepatocellular carcinoma disease (HCC), as well as diagnostic methods using the same
PL344534A1 (en) * 1997-11-28 2001-11-05 Innogenetics Nv Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
FR2773157B1 (fr) 1997-12-30 2001-10-05 Bio Merieux Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide
EP1107006B1 (en) 1998-08-21 2008-05-14 Ogata, Etsuro Method of diagnosing bone metastasis of malignant tumors
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
FR2795735B1 (fr) * 1999-07-01 2001-09-07 Univ Toulouse Derives citrullines de la fibrine et leur utilisation pour le diagnostic ou le traitement de la polyarthrite rhumatoide
CA2391356A1 (en) 1999-12-21 2001-06-28 Innogenetics N.V. Peptides designed for the diagnosis and treatment of rheumatoid arthritis
WO2001094616A1 (en) 2000-06-02 2001-12-13 Large Scale Proteomics Corp. Protein markers for pharmaceuticals and related toxicity
IL137307A0 (en) 2000-07-13 2001-07-24 Biopreventive Ltd A rapid non-invasive method for differential acute cardiac disease diagnosis
AU2001288921A1 (en) 2000-09-11 2002-03-26 Ciphergen Biosystems, Inc. Human breast cancer biomarkers
US20020072492A1 (en) * 2000-09-12 2002-06-13 Myers Timothy G. Non-genetic based protein disease markers
HN2001000224A (es) * 2000-10-19 2002-06-13 Pfizer Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
WO2002048310A2 (en) 2000-12-15 2002-06-20 Genetics Institute, Llc Methods and compositions for diagnosing and treating rheumatoid arthritis
US6500630B2 (en) * 2001-01-12 2002-12-31 Mayo Foundation For Medical Education And Research Marker for inflammatory conditions
NL1019540C2 (nl) * 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit.
US20030224386A1 (en) * 2001-12-19 2003-12-04 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
US20030175713A1 (en) 2002-02-15 2003-09-18 Clemens Sorg Method for diagnosis of inflammatory diseases using CALGRANULIN C
DE602004030586D1 (de) * 2003-09-15 2011-01-27 Oklahoma Med Res Found Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis

Also Published As

Publication number Publication date
ES2340328T3 (es) 2010-06-01
DE602004010432D1 (de) 2008-01-10
EP1700129B1 (en) 2007-11-28
JP4495168B2 (ja) 2010-06-30
PT1882946E (pt) 2010-04-21
JP2007515647A (ja) 2007-06-14
EP1882946A2 (en) 2008-01-30
DE602004010432T2 (de) 2008-12-04
CA2546312A1 (en) 2005-07-14
EP1700129A2 (en) 2006-09-13
DE602004025636D1 (de) 2010-04-01
CA2546312C (en) 2010-11-09
WO2005064307A2 (en) 2005-07-14
EP1882946A3 (en) 2008-02-13
ES2297521T3 (es) 2008-05-01
SI1882946T1 (sl) 2010-06-30
EP1882946B1 (en) 2010-02-17
US20070264673A1 (en) 2007-11-15
ATE458201T1 (de) 2010-03-15
US7846674B2 (en) 2010-12-07
PL1882946T3 (pl) 2010-07-30
CY1111229T1 (el) 2015-06-11
WO2005064307A3 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
CY1111229T1 (el) Μεθοδος προσδιορισμου ρευματοειδους αρθριτιδας με μετρηση αντι-ccp και ιντερλευκλινης 6
DK1721162T3 (da) Fremgangsmåde til at bedömme rheumatoid arthritis ved at måle anti-CCP og serumamyloid A
ATE522812T1 (de) Verfahren und zusammensetzung zum bestimmen von homocystein
HK1149956A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
DK1570274T3 (da) Analysator og analysefremgangsmåde og en væskekassette
ATE428929T1 (de) Reagens, ausstattung und verfahren zur probenanalyse
DK0659275T3 (da) Analytisk testapparat med indbygget negativ og positiv kontrol
ATE377450T1 (de) Mehrfach-kapillarsensor-analysesystem
ATE508360T1 (de) Verfahren, vorrichtungen und computerprogramme zum verifizieren der integrität einer sonde
DE602004031152D1 (de) Verfahren und system zum analysieren von reaktione
ATE541035T1 (de) Modifizierte creatininamid-hydrolase mit verbesserter substrataffinität und reagenszusammensetzung zur bestimmung von creatinin
DE60310012D1 (de) Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer
ATE524556T1 (de) Verfahren zur zyklischen nukleotid-bestimmung
HK1091540A1 (en) Use of a virus expressing a binding moiety to measure analytes in a sample
EP1605260A3 (de) Verfahren und Testkit zur Bestimmung des organisch gebundenen Kohlenstoffs (TOC)
ATE437372T1 (de) Verfahren zur messung von proinsulin und c-peptid sowie kit dafür
DE60121547D1 (de) Electrochemisches verfahren zum nachweis von nukleinsäuren
DK1664330T3 (da) Blod- og urintest
ATE465407T1 (de) Verfahren zum spezifischen nachweis von legionella pneumophila
FR2858413B1 (fr) Methode analytique d'identification de l'origine naturelle ou fossile de l'acide tartrique par determination du carbone 14-comptage en scintillation liquide
ATE339683T1 (de) Verfahren zur detektion und konzentrationsbestimmung von schwefelfreien odoriermitteln in erd- oder brenngas
DE59910326D1 (de) Verwendung derivatisierter Reagenzien in Chemilumineszenz- und Elektrochemilumineszenz-Nachweisverfahren
ATE305980T1 (de) Verwendung von abfangsonden beim nachweis von nukleinsäuren
NO20030461D0 (no) Analysemetode for plateaktiveringsfaktor
BRPI0512611A (pt) métodos e composições para a detecção de moléculas biológicas empregando um complexo de duas partìculas